Ubs Asset Management Americas Inc Zentalis Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.09 - $16.13 $187,788 - $740,592	45,914 Added 68.05%	113,386 $463,000
Q1 2024 May 15, 2024	BUY	$10.83 - $16.49 $46,525 - $70,841	4,296 Added 6.8%	67,472 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$9.84 - $20.13 $1.83 Million - $3.74 Million	-185,938 Reduced 74.64%	63,176 $957,000
Q3 2023 Nov 13, 2023	BUY	$19.63 - $28.29 $407,852 - $587,781	20,777 Added 9.1%	249,114 $5 Million
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $188,369 - $291,074	-11,671 Reduced 4.86%	228,337 $3.93 Million
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $255,003 - $361,267	14,112 Added 6.25%	240,008 $4.83 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $1.65 Million - $2.58 Million	81,401 Added 56.33%	225,896 $4.89 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $263,706 - $769,329	14,724 Added 11.35%	144,495 $4.06 Million
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $324,864 - $631,993	-7,813 Reduced 5.68%	129,771 $5.99 Million
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $7.85 Million - $9.94 Million	117,283 Added 577.72%	137,584 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $9,272 - $14,553	198 Added 0.98%	20,301 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $93,637 - $155,811	2,503 Added 14.22%	20,103 $1.07 Million
Q1 2021 May 14, 2021	BUY	$35.69 - $52.72 $217,709 - $321,592	6,100 Added 53.04%	17,600 $763,000
Q4 2020 Mar 01, 2021	BUY	$31.71 - $57.97 $364,665 - $666,655	11,500 New	11,500 $597,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.